Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Testosterone × Clear all

Phase

Status

Completed 5 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Eunuchism 2 Sarcopenia 1 Prostatic Neoplasms 1 Osteoporosis 1 Obesity 1 Non-alcoholic Fatty Liver Disease 1 Neoplasms 1 Metabolic Syndrome 1 Metabolic Diseases 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Arthralgia 1

Interventions

Exercise 18 Drug Therapy 16 pembrolizumab 11 Surveys and Questionnaires 11 Capecitabine 11 Blood Specimen Collection 11 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Biopsy 5 Bevacizumab 5 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00497458 2009-04-09

ART2

Havah Therapeutics Pty Ltd

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Osteoporosis, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡